Cargando…
Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies
A series of imidazothiazole derivatives possessing potential activity against melanoma cells were investigated for molecular mechanism of action. The target compounds were tested against V600E-B-RAF and RAF1 kinases. Compound 1zb is the most potent against both kinases with IC(50) values 0.978 and 8...
Autores principales: | Anbar, Hanan S., El-Gamal, Mohammed I., Tarazi, Hamadeh, Lee, Bong S., Jeon, Hong R., Kwon, Dow, Oh, Chang-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534351/ https://www.ncbi.nlm.nih.gov/pubmed/32962435 http://dx.doi.org/10.1080/14756366.2020.1819260 |
Ejemplares similares
-
Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori
por: Shahin, Afnan I., et al.
Publicado: (2023) -
Imidazothiazole Derivatives Exhibited Potent Effects against Brain-Eating Amoebae
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2022) -
Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023) -
Antiamoebic Activity of Imidazothiazole Derivatives against Opportunistic Pathogen Acanthamoeba castellanii
por: Akbar, Noor, et al.
Publicado: (2022) -
Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors
por: Serafini, Marta, et al.
Publicado: (2019)